Amphasys, a leader in real-time, single‑cell analysis technologies, and Arsenale Bioyards, a neo‑industrial biomanufacturing company pioneering a fully integrated biomanufacturing platform, today announced the signing of a Joint Development Agreement (JDA) to combine their respective technologies into a next‑generation platform for the development and operation of advanced bioprocesses.

Leman Biotech Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for META 10-19, a metabolically armored CD19-targeted CAR-T cell therapy.

Steffen Stürzebecher, MD, PhD, takes on the position of Chief Medical Officer (CMO). He joins the management team of Thomas Christély, CEO, and Marcus Thelen, PhD, CSO.

Data include a concurrent assessment of results collected from PGI and AMRA instruments, insights into clinically meaningful changes in HAE attack symptoms, and support for hierarchical ranking of RAPIDe-3 endpoints

BioLizard has been named “Bioinformatics Innovation of the Year” in the 2025 BioTech Breakthrough Awards. The honor spotlights Bio|Verse Navigator, a visual analytics workspace that unifies complex R&D data so scientists can decide faster, with confidence.